Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderately Impaired Renal Function”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03196206
What this trial is testing

Evaluate Pharmacokinetics and Safety of BMS-986177 in Participants With Normal Renal Function and With Moderate or Severe Renal Impairment

Who this might be right for
Thrombosis
Bristol-Myers Squibb 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT06004661
What this trial is testing

Study of Lutetium (177Lu) Vipivotide Tetraxetan in mCRPC Participants With Moderately and Severely Impaired and With Normal Renal Function

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Novartis Pharmaceuticals 23
Post-approval studies (Phase 4)Study completedNCT02812186
What this trial is testing

Deep Versus Moderate Neuromuscular Blockade During Laparoscopic Surgery

Who this might be right for
CholecystitisEndometriosisBowel Obstruction+4 more
Stony Brook University 79
Large-scale testing (Phase 3)Study completedNCT01064414
What this trial is testing

An Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment

Who this might be right for
Diabetes Mellitus, Type 2Renal Insufficiency
Janssen Research & Development, LLC 272
Not applicableStudy completedNCT04010630
What this trial is testing

Sodium Bicarbonate for the Treatment of Severe Metabolic Acidosis With Moderate or Severe Acute Kidney Injury in ICU

Who this might be right for
Metabolic AcidosisAcute Kidney Injury
University Hospital, Montpellier 640
Early research (Phase 1)Study completedNCT01527929
What this trial is testing

Pharmacokinetics and Safety Study of Cabazitaxel in Cancer Patients With Renal Impairment

Who this might be right for
Neoplasm Malignant
Sanofi 25
Large-scale testing (Phase 3)WithdrawnNCT00384657
What this trial is testing

Intravenous Iron in Patients With Severe Chronic Heart Failure and Chronic Kidney Disease

Who this might be right for
Chronic Kidney DiseaseChronic Heart FailureAnemia
Anemia Working Group Romania
Early research (Phase 1)Study completedNCT04656795
What this trial is testing

PK Study in Subjects With Renal Impairment (Severe and if Required Mild & Moderate) Compared to Subjects With Normal Renal Function

Who this might be right for
Renal ImpairmentNormal Renal Function
Tanabe Pharma America, Inc. 32
Not applicableEnded earlyNCT00364494
What this trial is testing

Hemodilution and Outcome in Cardiac Surgery

Who this might be right for
Kidney FailureIntraoperative Complications
Università Vita-Salute San Raffaele
Not applicableUnknownNCT06428942
What this trial is testing

Low-potassium Content Vegetables in Chronic Kidney Disease

Who this might be right for
the Recommended Target of Daily Vegetables IntakeRisk of Hyperkalemia
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation 75
Not applicableStudy completedNCT03472105
What this trial is testing

Short-term Effect of a New Nordic Renal Diet on Phosphorus Homeostasis in CKD Stage 3-4

Who this might be right for
Chronic Kidney Disease, Stage 3 (Moderate)
University of Copenhagen 18
Post-approval studies (Phase 4)Study completedNCT02178306
What this trial is testing

Efficacy and Safety of Telmisartan in Hypertensive Patients With Mild/Moderate or Severe Renal Impairment or Requiring Hemodialysis

Who this might be right for
Hypertension
Boehringer Ingelheim 82
Early research (Phase 1)Study completedNCT01613690
What this trial is testing

Comparing the Pharmacokinetics, Safety and Tolerability of NVA237 in Renal Impairment

Who this might be right for
Renal Impairment
Novartis Pharmaceuticals 48
Early research (Phase 1)Study completedNCT02219516
What this trial is testing

Mild, Moderate and Severe Renal Impairment Study

Who this might be right for
Gout
Ardea Biosciences, Inc. 31
Early research (Phase 1)Not Yet RecruitingNCT07797322
What this trial is testing

Investigate the Pharmacokinetics and Safety of PKN605 in Participants With Moderate and Severe Renal Impairment Compared to Matched Control Subjects With Normal Renal Function

Who this might be right for
Participants With Moderate and Severe Renal Impairment and Healthy Participants
Novartis Pharmaceuticals 40
Early research (Phase 1)Study completedNCT04142970
What this trial is testing

Safety and Pharmacokinetics/Pharmacodynamics of HSK3486 in Patients With Impairment Renal Functions

Who this might be right for
Chronic Renal Impairment
Sichuan Haisco Pharmaceutical Group Co., Ltd 24
Early research (Phase 1)Looking for participantsNCT07694869
What this trial is testing

A Phase I Clinical Trial to Evaluate the Pharmacokinetic Characteristics of Ammoxetine Hydrochloride Enteric-Coated Tablets in Participants With Moderate Renal Impairment and Normal Renal Function

Who this might be right for
Healthy ParticipantsParticipants With Moderate Renal Impairment
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 16
Testing effectiveness (Phase 2)Study completedNCT01043029
What this trial is testing

Aleglitazar in Type 2 Diabetes Patients With Moderate Renal Impairment

Who this might be right for
Diabetes Mellitus Type 2
Hoffmann-La Roche 302
Early research (Phase 1)Study completedNCT04471337
What this trial is testing

Study on the Safety of BAY1817080 How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Drug Given to Participants With Moderate Renal Impairment and End Stage Renal Disease Requiring Dialysis Compared With Matched Participants With Normal Renal Function

Who this might be right for
Endometriosis Related PainOveractive BladderDiabetic Neuropathic Pain+1 more
Bayer 32
Early research (Phase 1)Study completedNCT05070390
What this trial is testing

Enlicitide Chloride (MK-0616 Oral PCSK9 Inhibitor) in Participants With Moderate Renal Impairment (MK-0616-007)

Who this might be right for
Moderate Renal Impairment
Merck Sharp & Dohme LLC 18
Next Page